Geen internetverbinding — de opgeslagen versie van de pagina wordt getoond.

Alterity Therapeu…

AUAUD
← Naar de Screener

Alterity Therapeutics Ltd (US:PRNAF) — Biotechnology: Pharmaceutical Preparations. Aantal beurzen waarop de aandelen van het bedrijf worden verhandeld: 2. Op deze pagina — koers en grafiek, dividenden, grootste aandeelhouders en historiek van het aantal aandelen.

Over het Bedrijf

Website
alteritytherapeutics.com
Sector
Health Care · Biotechnology: Pharmaceutical Preparations
Hoofdkantoor
MELBOURNE, Australia
CEO
David A. Stamler
Werknemers
11
Uitstaande Aandelen
217.51 mln. per 2026-06-30
Free Float
171.39 mln.
Marktkapitalisatie
81.28 mln. AUD
Insiders
7.91%
Institutionele Beleggers
17.98%
Branche (SIC)
Pharmaceutical Preparations
Beschrijving

Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson's disease. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy, as well as bioMUSE, biomarkers of progression in multiple system atrophy. The company also operates drug discovery platform that generates patentable chemical compounds to treat the underlying pathology of neurological diseases. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is based in Melbourne, Australia.

advertentie

Beurzen en Tickers

BeursTickerValutaPrijsType
AU Australian Securities ExchangeATH primairAUD0.34 -2.86%gewone aandelen
US USA StocksPRNAF OTCUSD0.25 -37.50%gewone aandelen

Koers over 3 Maanden

stijgingsdag dalingsdagBeweeg over / tik op een dag — openings-, slot-, hoogste en laagste koers

Grootste Aandeelhouders

HouderBelangAandelenRapportdatum
Meltzer (Brian Derek) (F…≈49.36%9.42 mln.2025-11-21
Gozlan (Lawrence) (Direc…≈23.83%4.55 mln.2025-04-07
Marks (Peter Vincent) (I…≈1.19%227 7042026-08-31
Twin Lakes Capital Manag…0.73%139 2582026-06-30
Morgan Stanley0.33%63 0652026-06-30
Greenleaf Trust0.32%62 0002026-06-30
HB Wealth Management, LL…0.31%58 4602026-06-30
Citadel Advisors Llc0.2%37 5972026-06-30
Kempler (Geoffrey Paul)…≈0.16%30 0002025-11-21
HRT Financial LP0.09%17 2922026-06-30
BNP Paribas Financial Ma…0.05%10 2392026-06-30
Gamma Investing LLC0.01%2 3092026-06-30
Rhumbline Advisers0.01%2 0092026-06-30
Acadian Asset Management…0.01%1 8632026-06-30
Fidelity Concord Street…0.01%1 1552026-05-31
Stamler (David) (Chief E…—91.69 mln.2025-11-21